Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:47 pm Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 6,632,015 9.900% |
1,362,728 (+25.86%) |
Filing History |
| 2024-02-14 08:57 am Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Deep Track Capital, LP | 6,100,000 9.870% |
2,540,000 (+71.35%) |
Filing History |
| 2024-02-13 5:21 pm Unchanged |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
LAV Biosciences Fund V L.P. | 2,901,566 4.700% |
0 (Unchanged) |
Filing History |
| 2024-02-13 11:44 am Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,837,126 9.500% |
2,388,851 (+69.28%) |
Filing History |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 2,990,402 4.839% |
-2,127,648 (-41.57%) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
BLACKROCK INC BLK |
3,408,978 5.500% |
3,408,978 (New Position) |
Filing History |
| 2024-01-25 4:09 pm Purchase |
2024-01-18 | 13G | Terns Pharmaceuticals, Inc. TERN |
Integrated Core Strategies (US) LLC | 3,479,630 5.600% |
3,479,630 (New Position) |
Filing History |
| 2023-10-13 3:58 pm Sale |
2023-10-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 5,118,050 8.380% |
-2,260,591 (-30.64%) |
Filing History |
| 2023-10-10 09:09 am Purchase |
2023-10-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FIL Limited | 5,118,050 8.380% |
5,118,050 (New Position) |
Filing History |
| 2023-10-04 5:09 pm Sale |
2023-10-04 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 0 0.000% |
-2,851,287 (Position Closed) |
Filing History |
| 2023-07-28 4:25 pm Purchase |
2023-07-20 | 13G | Terns Pharmaceuticals, Inc. TERN |
Deep Track Capital, LP | 3,560,000 6.280% |
3,560,000 (New Position) |
Filing History |
| 2023-06-27 4:32 pm Purchase |
2023-06-20 | 13G | Terns Pharmaceuticals, Inc. TERN |
MILLENNIUM MANAGEMENT LLC | 2,313,370 4.100% |
2,313,370 (New Position) |
Filing History |
| 2023-03-29 5:24 pm Unchanged |
2023-03-27 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,619,135 13.400% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Venrock Healthcare Capital Partners III L.P. | 3,707,891 7.700% |
641,650 (+20.93%) |
Filing History |
| 2023-02-14 3:45 pm Purchase |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 5,269,287 9.900% |
3,219,287 (+157.04%) |
Filing History |
| 2023-02-13 5:57 pm Purchase |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Vivo Capital VIII LLC | 4,340,212 9.000% |
2,022,432 (+87.26%) |
Filing History |
| 2023-02-13 06:40 am Unchanged |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Auspice Ltd | 941,206 1.960% |
0 (Unchanged) |
Filing History |
| 2023-02-10 3:57 pm Unchanged |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 2,851,287 5.760% |
0 (Unchanged) |
Filing History |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 7,378,641 14.901% |
1,736,567 (+30.78%) |
Filing History |
| 2023-02-09 06:15 am Sale |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Auspice Ltd | 941,206 1.960% |
-470,000 (-33.30%) |
Filing History |